Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals

NCT02958982 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Stopped Significant recruitment delay in POC part

Conditions

Healthy Volunteers
Asthma

Interventions

DRUG: RP3128
DRUG: Placebo

Sponsor

Rhizen Pharmaceuticals SA